$2.23M in average volume shows that Fate Therapeutics Inc (FATE) is heading in the right direction

On November 20, 2023, Fate Therapeutics Inc (NASDAQ: FATE) opened at $2.44, higher 7.00% from the last session. During the day, the shares moved up to $2.70 and dropped to $2.385 before settling in for the closing price of $2.43. Price fluctuations for FATE have ranged from $1.63 to $21.47 over the past 52 weeks.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


During the last 5-year period, the sales growth of Healthcare Sector giant was 97.04%. Company’s average yearly earnings per share was noted 39.56% at the time writing. With a float of $92.76 million, this company’s outstanding shares have now reached $97.29 million.

Let’s determine the extent of company efficiency that accounts for 551 employees. In terms of profitability, gross margin is +85.71, operating margin of -320.23, and the pretax margin is -292.55.

Fate Therapeutics Inc (FATE) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Fate Therapeutics Inc is 5.92%, while institutional ownership is 105.32%. The most recent insider transaction that took place on Nov 09, was worth 58,471. In this transaction General Counsel and Secretary of this company sold 24,363 shares at a rate of $2.40, taking the stock ownership to the 153,235 shares. Before that another transaction happened on Aug 18, when Company’s Chief Financial Officer sold 4,718 for $2.80, making the entire transaction worth $13,210. This insider now owns 119,570 shares in total.

Fate Therapeutics Inc (FATE) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.46 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.57) by $0.11. This company achieved a net margin of -292.55 while generating a return on equity of -48.46. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 39.56% per share during the next fiscal year.

Fate Therapeutics Inc (NASDAQ: FATE) Trading Performance Indicators

Check out the current performance indicators for Fate Therapeutics Inc (FATE). In the past quarter, the stock posted a quick ratio of 8.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.41.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.77, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -2.03 in one year’s time.

Technical Analysis of Fate Therapeutics Inc (FATE)

Looking closely at Fate Therapeutics Inc (NASDAQ: FATE), its last 5-days average volume was 2.03 million, which is a drop from its year-to-date volume of 2.7 million. As of the previous 9 days, the stock’s Stochastic %D was 68.29%. Additionally, its Average True Range was 0.23.

During the past 100 days, Fate Therapeutics Inc’s (FATE) raw stochastic average was set at 28.12%, which indicates a significant decrease from 86.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.41% in the past 14 days, which was higher than the 80.45% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.08, while its 200-day Moving Average is $4.26. However, in the short run, Fate Therapeutics Inc’s stock first resistance to watch stands at $2.74. Second resistance stands at $2.88. The third major resistance level sits at $3.05. If the price goes on to break the first support level at $2.42, it is likely to go to the next support level at $2.25. Should the price break the second support level, the third support level stands at $2.11.

Fate Therapeutics Inc (NASDAQ: FATE) Key Stats

There are currently 98,602K shares outstanding in the company with a market cap of 256.36 million. Presently, the company’s annual sales total 96,300 K according to its annual income of -281,720 K. Last quarter, the company’s sales amounted to 1,940 K and its income totaled -45,170 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Rocket Pharmaceuticals Inc (RCKT) surge 12.73% in a week: will this be a lucky break through?

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) started the day on December 07, 2023, with a price increase of 1.82% at $26.30. During the day, the...

California Resources Corporation (CRC) Open at price of $49.34: A Brand-New Opportunity for Investors

California Resources Corporation (NYSE: CRC) open the trading on December 07, 2023, with a bit cautious approach as it glided -0.14% to $49.12. During...

Wayfair Inc (W) Open at price of $52.35: A Brand-New Opportunity for Investors

Witnessing the stock’s movement on the chart, on December 07, 2023, Wayfair Inc (NYSE: W) remained unchanged to $53.07. During the day, the stock...


Please enter your comment!
Please enter your name here